Interspecies Scaling: Predicting Pharmacokinetic Parameters of Antiepileptic Drugs in Humans from Animals with Special Emphasis on Clearance
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
The objective of this study was to test the interspecies-scaling approach in a series of antiepileptic drugs. Clearance, volume of distribution, and elimination half-life were scaled up from animal data obtained from literature. Four different methods were utilized to generate plots to scale up the clearance values: (i) clearance vs body weight (simple allometric equation); (ii) the product of clearance and maximum life-span potential (MLP) vs body weight (an approach recommended in literature); (iii) the two-term power equation which incorporates both body weight and brain weight suggested by Boxenbaum; and (iv) the product of clearance and brain weight vs body weight (a new approach being introduced in this study). When the predicted values for clearance were qualitatively compared with the observed values in humans, it was found that our proposed method predicted the clearance better than the other three methods. Using the simple allometric equation, the prediction of volume of distribution as a function of body weight was found to be satisfactory. The elimination half-life could not be predicted from simple allometric equations for any of the drugs studied; however, utilizing the equation CL = VK, prediction for half-life was feasible. The results of this study indicate that it is possible to predict reliably the pharmacokinetic parameters of these antiepileptic drugs in humans from animal data using an allometric approach.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“When MLP and brain weight were incorporated in simple AS, the predicted values showed good agreement with the observation values [89].”
From Interpretation of Non-Clinical Data for Prediction of Human Pharmacokinetic Parameters: In Vitro-In Vivo Extrapolation and Allometric Scaling (2019) · cites this paper as [89]
In the citing paper
“Because of the hybrid nature of the t1/2, this parameter has been poorly estimated by AS [89,114].”
From Interpretation of Non-Clinical Data for Prediction of Human Pharmacokinetic Parameters: In Vitro-In Vivo Extrapolation and Allometric Scaling (2019) · cites this paper as [89]
Citations
Cites
Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics
Boxenbaum, H. (1982) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01062336 · Cited by 648
Dedrick, R. L. (1973) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01059667 · Cited by 397
Man versus Beast: Pharmacokinetic Scaling in Mammals
Mordenti, J. (1986) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600751104 · Cited by 388
Boxenbaum, H. (1980) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01065191 · Cited by 347
Interspecies Pharmacokinetic Scaling and the Evolutionary-Comparative Paradigm
Boxenbaum, H. (1984) · Drug Metabolism Reviews · doi:10.3109/03602538409033558 · Cited by 267
Pharmacokinetics and plasma binding of diazepam in man, dog, rabbit, guinea pig and rat.
Klotz, U., Antonin, K. H., & Bieck, P. R. (1976) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30657-9 · Cited by 211
First‐Time‐in‐Human Dose Selection: Allometric Thoughts and Perspectives
Boxenbaum, H., & DiLea, C. (1995) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1995.tb04011.x · Cited by 161
Serum protein binding and pharmacokinetics of valproate in man, dog, rat and mouse.
Löscher, W. (1978) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)31137-7 · Cited by 129
(1992) · Drug Development and Industrial Pharmacy · doi:10.3109/03639049209043866 · Cited by 118
Comparative Pharmacokinetics of the Newer Antiepileptic Drugs
Bialer, M. (1993) · Clinical Pharmacokinetics · doi:10.2165/00003088-199324060-00002 · Cited by 100
Scaling of antipyrine intrinsic clearance of unbound drug in 15 mammalian species
Boxenbaum, H. G., & Fertig, J. B. (1984) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03189622 · Cited by 93
Pharmacokinetic Scale-up: Accurate Prediction of Human Pharmacokinetic Profiles from Animal Data
Mordenti, J. J. (1985) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600741017 · Cited by 87
Ciba Foundation Colloquia on Aging
Montagu, A. (1964) · American Journal of Psychiatry · doi:10.1176/ajp.120.7.727-a · Cited by 60
Time Concepts in Physics, Biology, and Pharmacokinetics
Boxenbaum, H. G. (1986) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600751107 · Cited by 47
Bachmann, K. (1989) · Journal of Applied Toxicology · doi:10.1002/jat.2550090509 · Cited by 39
Pharmacokinetics and pharmacodynamics of psychoactive drugs
de Zeeuw, R. A. (1986) · TrAC Trends in Analytical Chemistry · doi:10.1016/0165-9936(86)87015-7 · Cited by 27
Interspecies Scaling of Tebufelone Pharmacokinetic Data and Application to Preclinical Toxicology
Cruze, C. A., Kelm, G. R., & Meredith, M. P. (1995) · Pharmaceutical Research · doi:10.1023/a:1016273306956 · Cited by 25
Research works printed but not linked: 5
- Loscher, 1978, J. Pharmacol. Exp. Ther., 204, 255
- Klotz, 1976, J. Pharmacol. Exp. Ther., 199, 67
- EL Sayed, 1978, Arch. Int. Pharma-codyn., 234, 180
- Matsumoto, 1983, Arzneim-Forsch., 33, 961
- Dedrick, 1970, Cancer Chemother. Rep. Part1, 54, 95
Cited by
Martignoni, M., Groothuis, G. M. M., & de Kanter, R. (2006) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2.6.875 · Cited by 1,478
“a number of modifications were subsequently proposed for improving the accuracy of these predictions [6,7].”
BackgroundThe Prediction of Human Pharmacokinetic Parameters from Preclinical and in Vitro Metabolism Data
Obach, R. S., Baxter, J. G., Liston, T. E., Silber, B. M., Jones, B. C., Macintyre, F., Rance, D. J., & Wastall, P. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36999-x · Cited by 987
To Scale or Not to Scale: The Principles of Dose Extrapolation
Sharma, V., & McNeill, J. H. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00267.x · Cited by 544
“There is an advantage to using the Rule of Exponents with protein-binding correction in many cases.”
MethodInfluentialA Novel Strategy for Physiologically Based Predictions of Human Pharmacokinetics
Jones, H. M., Parrott, N., Jorga, K., & Lav??, T. (2006) · Clinical Pharmacokinetics · doi:10.2165/00003088-200645050-00006 · Cited by 352
“cases these methods give good predictions,[8-10] their The purpose of this work was to propose and physiological basis is questionable and inaccurate evaluate a PBPK strategy for the prediction of results are frequently obtained, particularly when human pharmacokinetics.”
MethodInterspecies Scaling: Predicting Clearance of Drugs in Humans. Three Different Approaches
Mahmood, I., & Balian, J. D. (1996) · Xenobiotica · doi:10.3109/00498259609052491 · Cited by 257
Self-citation
Metadata
- Authors
- Mahmood, I., & Balian, J. D.
- Affiliations
- United States Food and Drug Administration (US)
- Corresponding author
- Mahmood, Iftekhar
- ORCID
- Mahmood, Iftekhar
- Venue
- Journal of Pharmaceutical Sciences
- Publisher
- American Geophysical Union (AGU)
- Published
- 1996-04
- Volume
- 85
- Issue
- 4
- Pages
- 411-414
- ISSN
- 0022-3549 (ISSN-L)
- OpenAlex
- W2065457233
- Cited by
- 105
- References
- 17
- Citations by year
- 2025: 1 · 2024: 3 · 2023: 1 · 2022: 1 · 2020: 3 · 2019: 2 · 2017: 3 · 2016: 4 · 2015: 4 · 2014: 5 · 2013: 3 · 2012: 3
- FWCI
- 6.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Journal of Pharmaceutical Sciences (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Keywords
- interspecies scaling, antiepileptic drugs, pharmacokinetic prediction, drug clearance, allometric scaling, volume of distribution, elimination half-life, brain weight, body weight, animal-to-human extrapolation
- MeSH terms
- Animals, Anticonvulsants, Diazepam, Ethosuximide, Half-Life, Humans, Models, Biological, Species Specificity, Valproic Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.